Entry Detail



General Information

Database ID:exR0089875
RNA Name:hsa-miR-423-5p
RNA Type:miRNA
Chromosome:chr17
Starnd:+
Coordinate:
Start Site(bp):30117095End Site(bp):30117117
External Links:hsa-miR-423-5p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
DCAF7
chr17
63550477
63594279
+
PGAM1
chr10
97426191
97433444
+
MINK1
chr17
4833340
4898061
+
PSME3
chr17
42824385
42843760
+
LIMD2
chr17
63695888
63701172
-
SYVN1
chr11
65121780
65134533
-
KLC2
chr11
66257294
66267860
+
MYBL2
chr20
43667019
43716495
+
DLGAP4
chr20
36306336
36528637
+
CAPN15
chr16
527712
554636
+
MAPKBP1
chr15
41774434
41827855
+
PAK2
chr3
196739857
196832647
+
ACTN4
chr19
38647649
38731589
+
C1QTNF6
chr22
37180166
37199385
-
MAPK8IP2
chr22
50600793
50613981
+
BCORL1
chrX
129981107
130058083
+
FAM83H
chr8
143723933
143738234
-
WDR45B
chr17
82614562
82648553
-
CDCA7
chr2
173354820
173368997
+
PRR12
chr19
49591182
49626439
+
CHP1
chr15
41230839
41281887
+
TNFAIP3
chr6
137867214
137883312
+
IL2RB
chr22
37125843
37175054
-
RAB8A
chr19
16111889
16134234
+
HNRNPA2B1
chr7
26173057
26201529
-
ATN1
chr12
6924463
6942321
+
EIF5AL1
chr10
79512601
79516440
+
IGF2BP1
chr17
48997385
49056145
+
PPDPF
chr20
63520765
63522206
+
CTSD
chr11
1752755
1764573
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000540
chr14
55799534
55821940
+
hsa_circ_0001472
chr5
36953719
36976504
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC009133.5
chr16
29808679
29812227
+
AC016876.2
chr17
7581964
7584086
-
AC021078.1
chr5
149494314
149504670
-
AL356488.2
chr1
109100193
109100619
+
H19
chr11
1995176
2001470
-
KCNQ1OT1
chr11
2608328
2699994
-
MIR663AHG
chr20
26167817
26251546
-
MIRLET7BHG
chr22
46053869
46113928
+
NEAT1
chr11
65422774
65445540
+
STAG3L5P-PVRIG2P-PILRB
chr7
100336104
100367831
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.